GGRCX
Price
$13.28
Change
+$0.02 (+0.15%)
Updated
Mar 11 closing price
Net Assets
175.44M
VIGAX
Price
$191.54
Change
-$0.44 (-0.23%)
Updated
Mar 11 closing price
Net Assets
282.6B
Ad is loading...

GGRCX vs VIGAX

Header iconGGRCX vs VIGAX Comparison
Open Charts GGRCX vs VIGAXBanner chart's image
Goldman Sachs Strategic Growth C
Price$13.28
Change+$0.02 (+0.15%)
VolumeN/A
Net Assets175.44M
Vanguard Growth Index Admiral
Price$191.54
Change-$0.44 (-0.23%)
VolumeN/A
Net Assets282.6B
GGRCX vs VIGAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GGRCX vs. VIGAX commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGRCX is a Hold and VIGAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 283B vs. GGRCX (175M). VIGAX pays higher dividends than GGRCX: VIGAX (0.46) vs GGRCX (0.00). GGRCX was incepted earlier than VIGAX: GGRCX (26 years) vs VIGAX (24 years). GGRCX (2.07) is less costly to investors than VIGAX (0.05). GGRCX is a more actively managed with annual turnover of: 39.00 vs. VIGAX (5.00). GGRCX has a lower initial minimum investment than VIGAX: GGRCX (1000) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 10.53 vs. GGRCX (4.08). VIGAX return over 5 years is better than : 149.71 vs. GGRCX (6.76).
GGRCXVIGAXGGRCX / VIGAX
Total Expense Ratio1.780.053,560%
Annual Report Gross Expense Ratio2.070.054,140%
Fund Existence26 years24 years-
Gain YTD-10.163-9.109112%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets175M283B0%
Annual Yield % from dividends0.000.46-
Returns for 1 year4.0810.5339%
Returns for 3 years13.6244.1331%
Returns for 5 years6.76149.715%
Returns for 10 years-57.66250.43-23%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CVAC3.160.24
+8.22%
CureVac NV
XTNT0.44N/A
-0.11%
Xtant Medical Holdings
BEN19.62-0.41
-2.05%
Franklin Resources
RLMD0.27-0.01
-2.21%
Relmada Therapeutics
HTGC18.04-0.56
-3.01%
Hercules Capital